Remission can occur because of treatment, or it can happen spontaneously. For example, symptoms of autoimmune diseases like ...

Medically reviewed by Qin Rao, MD Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, ...

Crohn’s is a lifelong condition, and while it can go through periods of remission, flare-ups are a part of the disease’s cycle, causing unpredictable and challenging symptoms.

Crohn’s disease is a condition that causes inflammation in your gastrointestinal (GI) tract. Your GI tract is the system of organs that help you eat and digest food. Crohn’s disease is a chronic ...

Because Crohn's disease, also caused ileitis, is marked by many nutrient deficiencies, it can lead to complications in the eyes, skin, joints, and more. Learn about surprising Crohn's symptoms.

Crohn's disease is a chronic inflammatory disease of the digestive system. Both Crohn's disease and ulcerative colitis are referred to as inflammatory bowel disease (IBD), not to be mistaken for ...

While some evidence suggests that cannabis use may help relieve Crohn’s symptoms, more research is needed to show disease improvement. Here’s what you should know before you give it a try.

Crohn's disease is a serious inflammatory bowel disease (IBD) that impacts millions worldwide. The disease is chronic and highly unpredictable, manifesting symptoms such as abdominal pain, ...

Symptoms of Crohn's disease often show up in a person's late teens or 20s and can be life altering. While Crohn's isn't as well-known to the general public as some other digestive diseases like ...

Crohn’s disease: What you need to know as Daisy Cooper discusses life-threatening experience From symptoms to treatement Camilla Foster Tuesday 17 September 2024 12:33 BST ...

Crohn's disease is an autoimmune disorder that "causes inflammation in the lining of the gastrointestinal tract," says Dr. Miguel Regueiro, chair of the department of gastroenterology, hepatology ...

In my opinion, they have transformed the natural history of this disease. In 1998, the FDA approved the anti-TNF alpha-targeting medicationinfliximab to treat Crohn’s disease.